Julien Garnon1,2, Roberto Luigi Cazzato3, Pierre Auloge3, Nitin Ramamurthy4, Guillaume Koch3, Afshin Gangi3. 1. Department of interventional radiology, Nouvel Hôpital Civil, 1, place de l'hôpital, 67096, Strasbourg Cedex, France. juliengarnon@gmail.com. 2. UMR 7357, CNRS, INSA Strasbourg, ICube - University of Strasbourg, 1 place de l'Hôpital, 67091, Strasbourg, France. juliengarnon@gmail.com. 3. Department of interventional radiology, Nouvel Hôpital Civil, 1, place de l'hôpital, 67096, Strasbourg Cedex, France. 4. Department of Radiology, Norfolk and Norwich University Hospital, Norwich, UK.
Abstract
OBJECTIVE: To report the technique of hydrodissection of the sub-diaphragmatic bare area of the liver, in order to protect the diaphragm/heart during percutaneous thermal ablation (PTA) of sub-cardiac hepatic tumours. MATERIALS AND METHODS: Between January 2016 and December 2018, five patients (four female, one male; mean age 56.2 years) with five sub-cardiac liver tumours (two hepatocellular carcinoma, three metastases; mean size 39 mm) abutting the bare area (segments II/IVA) with expected ablation zones ≤ 5 mm from the myocardium were treated with PTA and adjunctive hydrodissection. Time to perform hydrodissection, distance between superior hepatic and diaphragmatic/pericardial surfaces before and after hydrodissection, ablation efficacy, complications, and local tumour progression (LTP) at last imaging follow-up were recorded. RESULTS: Technical feasibility was 100%, with mean hydrodissection-volume of 126 ml (range 80-200 ml) and median hydrodissection-time of 9 min (range 8-45 min). Liver-diaphragmatic and liver-pericardial distance increased, respectively, from 2.4 mm (range 0-8 mm) to 10.8 mm (range 6-19 mm) and from 4 mm (range 1-10 mm) to 12.6 mm (range 8-20 mm) post-hydrodissection. All procedures were performed at full-power with complete tumour ablation and without complications (including peri-procedural haemodynamic/electrocardiographic disturbances, pericardial effusion and diaphragmatic hernia) or evidence of LTP at mean 12.2-month (range 1-26 month) follow-up. CONCLUSION: Hydrodissection of the sub-diaphragmatic bare area of the liver is technically feasible and may potentially optimize safety PTA of sub-cardiac hepatic tumours.
OBJECTIVE: To report the technique of hydrodissection of the sub-diaphragmatic bare area of the liver, in order to protect the diaphragm/heart during percutaneous thermal ablation (PTA) of sub-cardiac hepatic tumours. MATERIALS AND METHODS: Between January 2016 and December 2018, five patients (four female, one male; mean age 56.2 years) with five sub-cardiac liver tumours (two hepatocellular carcinoma, three metastases; mean size 39 mm) abutting the bare area (segments II/IVA) with expected ablation zones ≤ 5 mm from the myocardium were treated with PTA and adjunctive hydrodissection. Time to perform hydrodissection, distance between superior hepatic and diaphragmatic/pericardial surfaces before and after hydrodissection, ablation efficacy, complications, and local tumour progression (LTP) at last imaging follow-up were recorded. RESULTS: Technical feasibility was 100%, with mean hydrodissection-volume of 126 ml (range 80-200 ml) and median hydrodissection-time of 9 min (range 8-45 min). Liver-diaphragmatic and liver-pericardial distance increased, respectively, from 2.4 mm (range 0-8 mm) to 10.8 mm (range 6-19 mm) and from 4 mm (range 1-10 mm) to 12.6 mm (range 8-20 mm) post-hydrodissection. All procedures were performed at full-power with complete tumour ablation and without complications (including peri-procedural haemodynamic/electrocardiographic disturbances, pericardial effusion and diaphragmatic hernia) or evidence of LTP at mean 12.2-month (range 1-26 month) follow-up. CONCLUSION: Hydrodissection of the sub-diaphragmatic bare area of the liver is technically feasible and may potentially optimize safety PTA of sub-cardiac hepatic tumours.
Entities:
Keywords:
Bare area of the liver; Heart; Hydrodissection; Thermal ablation
Authors: George A Carberry; Amanda R Smolock; Mircea Cristescu; Shane A Wells; Timothy J Ziemlewicz; Meghan G Lubner; J Louis Hinshaw; Christopher L Brace; Fred T Lee Journal: J Vasc Interv Radiol Date: 2017-02-10 Impact factor: 3.464
Authors: Amanda R Smolock; Meghan G Lubner; Timothy J Ziemlewicz; J Louis Hinshaw; Douglas R Kitchin; Christopher L Brace; Fred T Lee Journal: AJR Am J Roentgenol Date: 2015-01 Impact factor: 3.959
Authors: Tae Wook Kang; Hyunchul Rhim; Eun Young Kim; Young Sun Kim; Dongil Choi; Won Jae Lee; Hyo K Lim Journal: Korean J Radiol Date: 2009 Jan-Feb Impact factor: 3.500
Authors: Louis Delmas; Guillaume Koch; Roberto Luigi Cazzato; Julia Weiss; Pierre Auloge; Danoob Dalili; Pierre de Marini; Afshin Gangi; Julien Garnon Journal: Abdom Radiol (NY) Date: 2021-04-12